Test Directory
| Test Code | |||
| TGFBP | |||
| Test Name | |||
| Transforming Growth Factor beta1 | |||
| CPT Codes | |||
| 83520 | |||
| Expected Turnaround Time | |||
| 8 - 14 days | |||
| Clinical Utility | |||
|
This is a quantitative EIA assay for the human cytokine Transforming Growth Factor beta 1 ( TGF ß-1). TGF β-1 plays a role in tissue regulation and is used as an aid to determine underlying causes of unusual or inflammatory disorders. TGF β-1 is a pleotropic cytokine that possesses both inflammatory and immune-suppressive characteristics. It is a secreted protein that performs many cellular functions, including control of cell growth, proliferation, differentiation and apoptosis. |
|||
| Specimen and Container Info | |||
|
Specimen Type: Platelet Poor Plasma (EDTA) Collection Container: Lavender Top (EDTA) Desired Specimen Volume: 1 mL |
|||
| Collection Instructions | |||
|
|||
| Processing and Submission Instructions | |||
|
|||
| Transport Instructions | |||
|
Transport to the laboratory frozen. |
|||
| Stability Requirements | |||
|
|||
| Causes for Rejection | |||
|
|||
| Methodology | |||
| Microfluidics ELISA | |||
| Reference Intervals | |||
|
See patient report. |
|||
| Limitations | |||
|
TGF-b1 results are directly affected by sample quality. Compromised samples can produce falsely elevated results. Samples must be collected by venipuncture and processed to be platelet poor. Indicators of poor sample quality or improper processing may include hemolysis. |
|||
| Reference Lab | |||
| Labcorp Of America Holdings | |||
| Testing Schedule | |||
| Monday-Friday | |||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.